UA80978U - Method for treating non-alcoholic fatty liver disease in patients with diabetes mellitus type 2 - Google Patents

Method for treating non-alcoholic fatty liver disease in patients with diabetes mellitus type 2

Info

Publication number
UA80978U
UA80978U UAU201301169U UAU201301169U UA80978U UA 80978 U UA80978 U UA 80978U UA U201301169 U UAU201301169 U UA U201301169U UA U201301169 U UAU201301169 U UA U201301169U UA 80978 U UA80978 U UA 80978U
Authority
UA
Ukraine
Prior art keywords
patients
diabetes mellitus
liver disease
fatty liver
alcoholic fatty
Prior art date
Application number
UAU201301169U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Петр Николаевич Боднар
Дмитрий Станиславович Янковский
Галина Петровна Михальчишин
Татьяна Владимировна Береговая
Татьяна Михайловна Фалалеева
Галина Семеновна Димент
Назарий Николаевич Кобыляк
Original Assignee
Национальный Медицинский Университет Им. А.А. Богомольца
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Медицинский Университет Им. А.А. Богомольца filed Critical Национальный Медицинский Университет Им. А.А. Богомольца
Priority to UAU201301169U priority Critical patent/UA80978U/en
Publication of UA80978U publication Critical patent/UA80978U/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A method for treating non-alcoholic fatty liver disease in the patients with diabetes mellitus type 2 provides for the use of medicamentous agents. Prior to the beginning of the treatment, the functional state of the liver is assessed. The levels of total cholesterol and triglycerides are measured. Symbiter acidophilic concentrated is used as probiotic, one sachet () once a day with the meal or after the meal for 30 days.
UAU201301169U 2013-01-31 2013-01-31 Method for treating non-alcoholic fatty liver disease in patients with diabetes mellitus type 2 UA80978U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201301169U UA80978U (en) 2013-01-31 2013-01-31 Method for treating non-alcoholic fatty liver disease in patients with diabetes mellitus type 2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201301169U UA80978U (en) 2013-01-31 2013-01-31 Method for treating non-alcoholic fatty liver disease in patients with diabetes mellitus type 2

Publications (1)

Publication Number Publication Date
UA80978U true UA80978U (en) 2013-06-10

Family

ID=51949500

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201301169U UA80978U (en) 2013-01-31 2013-01-31 Method for treating non-alcoholic fatty liver disease in patients with diabetes mellitus type 2

Country Status (1)

Country Link
UA (1) UA80978U (en)

Similar Documents

Publication Publication Date Title
HN2011002406A (en) 2-ACETAMIDO-5-ARIL-1,2,4-SUBSTITUTED TRIAZOLONES AND ITS USE
MX2013011835A (en) Nutritional compositions including branched chain fatty acids for wound healing.
PH12015500407B1 (en) Methods of treating hypertriglyceridemia
ECSP12012125A (en) ARILTRIAZOLONAS LINKED TO BISARILO AND ITS USE
MX2015009037A (en) Honey nasal rinse.
NZ778131A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
SV2011003901A (en) ARILO COMPOUNDS WITH HETEROCYCLIC SUBSTITUTES AS HIF INHIBITORS
NZ702169A (en) The use of heat shock protein 90 (hsp90) modulators for the treatment of metabolic syndrome
IN2015DN02729A (en)
FR2969495B1 (en) EXTRACT OF MACA-RICH AERIAL PARTS OF POLYPHENOLS AND COMPOSITION COMPRISING THE SAME
BR112014008700A2 (en) compositions useful in the treatment of nephropathy and processes for preparing same
GEP20196969B (en) New therapeutical composition containing apomorphine as active ingredient
SG10201906172XA (en) Regulation of glucose metabolism using anti-cgrp antibodies
MX2014005895A (en) Medicine for treatment and/or improvement of sepsis.
WO2013023641A3 (en) Method for producing a composition for application to the skin
BR112016028561A2 (en) composition, dosage form, and methods for reducing the risk for mortality in an individual, the risk for a disease or condition in an individual, triglycerides in an individual's blood, an individual's resting heart rate, lipoprotein cholesterol non-high density in an individual, total cholesterol in an individual, apolipoprotein b in an individual blood, systolic blood pressure in an individual, and diastolic blood pressure in an individual, to prolong an individual's life, to treat hypertriglyceridemia in an individual and to increase an omega-3 index in an individual's red blood cells.
MX2010007527A (en) Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases.
UA80978U (en) Method for treating non-alcoholic fatty liver disease in patients with diabetes mellitus type 2
WO2012169897A8 (en) Weight reducing material
WO2012040444A3 (en) Treatment of patients with incipient alzheimer's disease
WO2014150959A3 (en) Method and products for enhancing cellular uptake of drug and dietary supplements
UA82250U (en) Method for treating patients with non-alcoholic fatty liver disease
Riad Erythema, pruritus and skin crusting: case report
UA103788U (en) Method for treatment of acute coronary syndrome without st-segment elevation in patients with ischemic heart disease and metabolic syndrome following percutaneous transluminar coronary angioplasty
UA50454U (en) Method for treating and prophylaxis of bee varroosis